90 results on '"Pinto, L."'
Search Results
2. Analysis of the interaction of antimalarial agents with Plasmodium falciparum glutathione reductase through molecular mechanical calculations
- Author
-
Ferreira, Frederico Henrique do C., Pinto, L. R., Oliveira, B. A., Daniel, L. V., Navarro, M., and Delgado, G. Y. Sánchez
- Published
- 2024
- Full Text
- View/download PDF
3. Accuracy and Interpretation of Transcutaneous Carbon Dioxide Monitoring in Critically Ill Children
- Author
-
Setar, Leah, Lee, Jessica G., Sanchez-Pinto, L. Nelson, and Coates, Bria M.
- Published
- 2024
- Full Text
- View/download PDF
4. The Pediatric Data Science and Analytics Subgroup of the Pediatric Acute Lung Injury and Sepsis Investigators Network: Use of Supervised Machine Learning Applications in Pediatric Critical Care Medicine Research
- Author
-
Heneghan, Julia A., Walker, Sarah B., Fawcett, Andrea, Bennett, Tellen D., Dziorny, Adam C., Sanchez-Pinto, L. Nelson, Farris, Reid W. D., Winter, Meredith C., Badke, Colleen, Martin, Blake, Brown, Stephanie R., McCrory, Michael C., Ness-Cochinwala, Manette, Rogerson, Colin, Baloglu, Orkun, Harwayne-Gidansky, Ilana, Hudkins, Matthew R., Kamaleswaran, Rishikesan, Gangadharan, Sandeep, Tripathi, Sandeep, Mendonca, Eneida A., Markovitz, Barry P., Mayampurath, Anoop, and Spaeder, Michael C.
- Published
- 2024
- Full Text
- View/download PDF
5. Machine learning-driven identification of the gene-expression signature associated with a persistent multiple organ dysfunction trajectory in critical illness
- Author
-
Cvijanovich, Natalie Z., Fitzgerald, Julie C., Weiss, Scott L., Bigham, Michael T., Jain, Parag N., Schwarz, Adam J., Lutfi, Riad, Nowak, Jeffrey, Allen, Geoffrey L., Thomas, Neal J., Grunwell, Jocelyn R., Baines, Torrey, Quasney, Michael, Haileselassie, Bereketeab, Lindsell, Chris J., Atreya, Mihir R., Banerjee, Shayantan, Lautz, Andrew J., Alder, Matthew N., Varisco, Brian M., Wong, Hector R., Muszynski, Jennifer A., Hall, Mark W., Sanchez-Pinto, L. Nelson, and Kamaleswaran, Rishikesan
- Published
- 2024
- Full Text
- View/download PDF
6. Geometric morphometrics of face profile across horse breeds and within Arabian horses
- Author
-
Alhaddad, H., Powell, B.B., Pinto, L. Del, Sutter, N., Brooks, S.A., and Alhajeri, B.H.
- Published
- 2024
- Full Text
- View/download PDF
7. Performance of Tools and Measures to Predict Fluid Responsiveness in Pediatric Shock and Critical Illness: A Systematic Review and Meta-Analysis*
- Author
-
Walker, Sarah B., Winters, Jessica M., Schauer, Jacob M., Murphy, Peggy, Fawcett, Andrea, and Sanchez-Pinto, L. Nelson
- Published
- 2024
- Full Text
- View/download PDF
8. 1289: EXCESS DAILY BLOOD COUNT SAMPLING IN CHILDREN: A PICU DATA COLLABORATIVE STUDY
- Author
-
Shah, Sareen, Dziorny, Adam, Flynn, Alysia, Aczon, Melissa, Farris, Reid, Horvat, Christopher, Tawfik, Daniel, Bennett, Tellen, Cornell, Timothy, Nishisaki, Akira, Kennedy, Curtis, Nelson Sanchez-Pinto, L., and Wetzel, Randall
- Published
- 2024
- Full Text
- View/download PDF
9. 896: DEVELOPMENT OF A MULTICENTER CLOUD DATABASE AND LINKED BIOREPOSITORY FOR PEDIATRIC SEPSIS RESEARCH
- Author
-
Nelson Sanchez-Pinto, L., Daniels, Latasha, Jean Simon, Norma, Lindell, Robert, Alpern, Elizabeth, Grundmeier, Robert, and Balamuth, Frances
- Published
- 2024
- Full Text
- View/download PDF
10. 899: METABOLOMIC PROFILE OF HIGH-RISK PHENOTYPE OF SEPSIS-ASSOCIATED MODS: PERSISTENT HYPOXEMIA AND SHOCK
- Author
-
Hurtado, Ryan and Nelson Sanchez-Pinto, L.
- Published
- 2024
- Full Text
- View/download PDF
11. 895: IMMUNE PHENOTYPING RESULTS IN PEDIATRIC SEPSIS PATIENTS: IMPACT OF PREPROCESSING TIME INTERVALS
- Author
-
Lindell, Robert, Sayed, Samir, Henrickson, Sarah, Gollomp, Kandace, Grundmeier, Robert, Weiss, Scott, Alpern, Elizabeth, Nelson Sanchez-Pinto, L., and Balamuth, Frances
- Published
- 2024
- Full Text
- View/download PDF
12. 862A: Association Between Medical Complexity and Preferred Language in the Pediatric Intensive Care Unit
- Author
-
Pilarz, Mary, Bleed, Elizabeth, Rodriguez, Victoria, Daniels, Latasha, Jackson, Kathryn, Nelson Sanchez-Pinto, L., and Foster, Carolyn
- Published
- 2024
- Full Text
- View/download PDF
13. 791: PEDIATRIC SOFA SCORES ARE ASSOCIATED WITH CODE EVENTS IN CRITICALLY ILL CHILDREN
- Author
-
Wang, Austin, Daniels, Latasha, Nelson Sanchez-Pinto, L., and Badke, Colleen
- Published
- 2024
- Full Text
- View/download PDF
14. 26: THE INCREASING INCIDENCE OF INVASIVE BACTERIAL INFECTIONS DURING THE COVID-19 PANDEMIC
- Author
-
Martin, Blake, DeWitt, Peter, Russell, Seth, Haendel, Melissa, Sanchez-Pinto, L. Nelson, Albers, David, Jhaveri, Ravi, Moffitt, Richard, and Bennett, Tellen
- Published
- 2024
- Full Text
- View/download PDF
15. Medical Complexity, Language Use, and Outcomes in the Pediatric ICU.
- Author
-
Pilarz, Mary S., Bleed, Elizabeth, Rodriguez, Victoria A., Daniels, Latasha A., Jackson, Kathryn L., Sanchez-Pinto, L. Nelson, and Foster, Carolyn C.
- Published
- 2024
- Full Text
- View/download PDF
16. Biomarker Assessment of a High-Risk, Data-Driven Pediatric Sepsis Phenotype Characterized by Persistent Hypoxemia, Encephalopathy, and Shock.
- Author
-
Atreya, Mihir R., Bennett, Tellen D., Geva, Alon, Faustino, E. Vincent S., Rogerson, Colin M., Lutfi, Riad, Cvijanovich, Natalie Z., Bigham, Michael T., Nowak, Jeffrey, Schwarz, Adam J., Baines, Torrey, Haileselassie, Bereketeab, Thomas, Neal J., Yuan Luo, and Sanchez-Pinto, L. Nelson
- Published
- 2024
- Full Text
- View/download PDF
17. Cannabinoid type 2 receptor inhibition enhances the antidepressant and proneurogenic effects of physical exercise after chronic stress.
- Author
-
Rodrigues, R. S., Moreira, J. B., Mateus, J. M., Barateiro, A., Paulo, S. L., Vaz, S. H., Lourenço, D. M., Ribeiro, F. F., Soares, R., Loureiro-Campos, E., Bielefeld, P., Sebastião, A. M., Fernandes, A., Pinto, L., Fitzsimons, C. P., and Xapelli, S.
- Published
- 2024
- Full Text
- View/download PDF
18. Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock.
- Author
-
Sanchez-Pinto, L. Nelson, Bennett, Tellen D., DeWitt, Peter E., Russell, Seth, Rebull, Margaret N., Martin, Blake, Akech, Samuel, Albers, David J., Alpern, Elizabeth R., Balamuth, Fran, Bembea, Melania, Chisti, Mohammod Jobayer, Evans, Idris, Horvat, Christopher M., Jaramillo-Bustamante, Juan Camilo, Kissoon, Niranjan, Menon, Kusum, Scott, Halden F., Weiss, Scott L., and Wiens, Matthew O.
- Subjects
- *
SEPTIC shock , *SEPSIS , *RECEIVER operating characteristic curves , *RESOURCE-limited settings - Abstract
Key Points: Question: What are the best-performing organ dysfunction–based criteria to implement the definition of sepsis and septic shock in children with suspected infection? Findings: In this international, multicenter, retrospective cohort study including more than 3.6 million pediatric encounters, a novel score, the Phoenix Sepsis Score, was derived and validated to predict mortality in children with suspected or confirmed infection. The new criteria for pediatric sepsis and septic shock based on the score performed better than existing organ dysfunction scores and the International Pediatric Sepsis Consensus Conference criteria. Meaning: The new data-driven criteria for pediatric sepsis and septic shock based on measures of organ dysfunction had improved performance compared with prior pediatric sepsis criteria. Importance: The Society of Critical Care Medicine Pediatric Sepsis Definition Task Force sought to develop and validate new clinical criteria for pediatric sepsis and septic shock using measures of organ dysfunction through a data-driven approach. Objective: To derive and validate novel criteria for pediatric sepsis and septic shock across differently resourced settings. Design, Setting, and Participants: Multicenter, international, retrospective cohort study in 10 health systems in the US, Colombia, Bangladesh, China, and Kenya, 3 of which were used as external validation sites. Data were collected from emergency and inpatient encounters for children (aged <18 years) from 2010 to 2019: 3 049 699 in the development (including derivation and internal validation) set and 581 317 in the external validation set. Exposure: Stacked regression models to predict mortality in children with suspected infection were derived and validated using the best-performing organ dysfunction subscores from 8 existing scores. The final model was then translated into an integer-based score used to establish binary criteria for sepsis and septic shock. Main Outcomes and Measures: The primary outcome for all analyses was in-hospital mortality. Model- and integer-based score performance measures included the area under the precision recall curve (AUPRC; primary) and area under the receiver operating characteristic curve (AUROC; secondary). For binary criteria, primary performance measures were positive predictive value and sensitivity. Results: Among the 172 984 children with suspected infection in the first 24 hours (development set; 1.2% mortality), a 4-organ-system model performed best. The integer version of that model, the Phoenix Sepsis Score, had AUPRCs of 0.23 to 0.38 (95% CI range, 0.20-0.39) and AUROCs of 0.71 to 0.92 (95% CI range, 0.70-0.92) to predict mortality in the validation sets. Using a Phoenix Sepsis Score of 2 points or higher in children with suspected infection as criteria for sepsis and sepsis plus 1 or more cardiovascular point as criteria for septic shock resulted in a higher positive predictive value and higher or similar sensitivity compared with the 2005 International Pediatric Sepsis Consensus Conference (IPSCC) criteria across differently resourced settings. Conclusions and Relevance: The novel Phoenix sepsis criteria, which were derived and validated using data from higher- and lower-resource settings, had improved performance for the diagnosis of pediatric sepsis and septic shock compared with the existing IPSCC criteria. This cohort study derives and validates novel criteria for diagnosis of pediatric sepsis and septic shock across high-resource and low-resource international settings. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. FROM 3D SURVEY TO DIGITAL REALITY OF A COMPLEX ARCHITECTURE: A DIGITAL WORKFLOW FOR CULTURAL HERITAGE PROMOTION.
- Author
-
Fascia, R., Barbieri, F., Gaspari, F., Ioli, F., and Pinto, L.
- Subjects
CULTURAL property ,DRONE aircraft ,VIRTUAL tourism ,ART museums ,WORKFLOW ,DIGITAL technology ,OPTICAL scanners - Abstract
In recent years, the digitalization and dissemination of historical heritage have become crucial nodes in the preservation and valorization of Cultural Heritage (CH). Technologies such as Unmanned Aerial Vehicle (UAV) and terrestrial photogrammetry, Terrestrial Laser Scanning (TLS) and handheld Simultaneous Localisation and Mapping (SLAM) laser scanning allow the generation of digital models of architecture that can be explored through interactive web platforms, such as those based on WebGL graphic library. These are considered one of the most promising innovations for digitizing and sharing CH site due to their application in a wide range of contexts, promoting new forms of interaction with architecture at different scales. Additionally, the use of geomatic tools allows for a more complete 3D reconstruction and evaluation of the results by comparing different techniques. The article focuses on digitization as a tool for documenting and sharing CH assets, with the aim of developing a replicable prototype platform for an immersive Virtual Tour (VT) of an art collection and the architectural complex in which it is resided. In addition, this paper presents the results of a case study conducted at the Ricci Oddi Gallery of Modern Art in Piacenza, Italy. The source code of the implemented application is available on GitHub to permit replicability for other case studies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Chapter 43 - Infections and Behçet Disease
- Author
-
Sahin, Meyha, Correia, J., Campar, A., Ferrão, C., Serpa Pinto, L., Vasconcelos, Carlos, Yilmaz, Mesut, and Mahroum, Naim
- Published
- 2024
- Full Text
- View/download PDF
21. Phoenix Criteria for Pediatric Sepsis and Septic Shock—Reply.
- Author
-
Bennett, Tellen D., Argent, Andrew C., and Sanchez-Pinto, L. Nelson
- Subjects
SEPTIC shock ,SEPSIS ,MACHINE learning ,PEDIATRICIANS - Published
- 2024
- Full Text
- View/download PDF
22. Contributors
- Author
-
Abu-Shakra, Mahmoud, Adiguzel, Yekbun, Al Shawaf, Maisam, Alghory, Amal, Almeida, Isabel, Alrais, Mahmoud, Alrifaai, Mohamad Aosama, Alwani, Abdulkarim, Alwani, Abdulrahman, Amital, Howard, Anna, Dubaniewicz, Arleevskaya, Marina, Ashkenazi, Shai, Athanassiou, Lambros, Athanassiou, Panagiotis, Atik, Houda, Atzeni, Fabiola, Balbir-Gurman, Alexandra, Balcioglu, Zeynep Betul, Baldini, Chiara, Barbour, Mohammad, Bashi, Tomer, Belyaeva, Irina V., Ben-Ami, Dana, Blank, Miri, Boccassini, Laura, Bogdanos, Dimitrios P., Bombardieri, Stefano, Bost, Chloé, Brandão, Mariana, Braun-Moscovici, Yolanda, Brooks, Wesley H., Campar, A., Carvalheiras, Graziela, Cervera, R., Churilov, Leonid P., Cohen, Eytan, Correia, J., Darkhabani, Mohammad, David, Paula, de Carvalho, Jozélio Freire, Deniz, Omer Faruk, Detrick, Barbara, Deutsch, Melanie, Di Battista, Marco, Dogan, Emir, Dogru, Omer Faruk, Domingues, Vital Da Silva, Dotan, Arad, Dow, Coad Thomas, Durai, Malarvizhi, Elefante, Elena, Elsalti, Abdulrahman, Erman, Mikhail V., Esirgun, Sevval Nil, Ferrão, C., Ferreira, Álvaro, Ferro, Francesco, Fonseca, Tomás, Garg, Ravindra Kumar, Guilherme, Luiza, Habra, Mona, Halpert, Gilad, Hammerstad, Sara Salehi, Hooks, John J., Ilchovska, Daisy, Invernizzi, Pietro, Israeli, E., Janket, Sok-Ja, Kalil, Jorge, Karaoglan, Birnur Sinem, Kiyak, Zeynep, Kol, Mustafa Yusuf, Kostoglou-Athanassiou, Ifigenia, Krause, Ilan, Kudryavtsev, Igor V., Kumar, Neeraj, Lavine, Noy, Lerman, Tsahi T., Levi, Assi, Ling, Eduard, Moutsopoulos, Haralampos M., Mahajna, Hussein, Mahroum, Naim, Malhotra, Hardeep Singh, Malkova, Аnna M., Maoz-Segal, Ramit, Marinho, António, Mavragani, Clio P., Meurman, Jukka H., Milhes, Jean, Mimouni, Daniel, Morais, Cátia Iracema, Moudgil, Kamal D., Muniz Caldas, Cezar Augusto, Neves, Esmeralda, Neyestani, Kamyar, Nikolaev, Alexei V., Noversa de Sousa, Rita, Ohayon, Aviran, Palumbo, Antonino, Pasoto, Sandra Gofinet, Petríková, Jana, Puxeddu, Ilaria, Raftopoulou, Sylvia, Renaudineau, Yves, Ribeiro, Francinne Machado, Rigopoulou, Eirini I., Rosário, Cristina, Rossa, Alessandra Della, Sahin, Meyha, Sarzi-Puttini, Piercarlo, Seguro, Luciana Parente Costa, Seida, Isa, Seida, Ravend, Serpa Pinto, L., Sharon, Eran, Shoenfeld, Yehuda, Smyk, Daniel S., Sousa, Rita Catarina Medeiros, Starshinova, Anna A., Tamimi, Faleh, Tocut, Milena, Tomer, Yaron, Tunitsky-Lifshitz, Yulia, Vasconcelos, Carlos, Vasconcelos, Júlia, Vassilopoulos, Dimitrios, Venkatesha, Shivaprasad H., Villanueva, Ronald, Vita, Pedro, Yablonskiy, Piotr K., Yilmaz, Mesut, Zamorano, Bryan, Zandman-Goddard, Gisele, Zinchenko, Yulia S., and Zoubi, Magdi
- Published
- 2024
- Full Text
- View/download PDF
23. 316 Machine Learning to Predict Fluid Responsiveness in Hypotensive Children.
- Author
-
Walker, Sarah B., Honegger, Kyle S., Carroll, Michael S., Weese-Mayer, Debra E., and Sanchez-Pinto, L. Nelson
- Abstract
The given document is an abstract from the Journal of Clinical & Translational Science. It discusses the use of machine learning to predict fluid responsiveness in hypotensive children. The study aims to develop a model that can accurately predict which children will have a sustained response to fluid bolus. The researchers will conduct a retrospective observational cohort study and use physiologic and clinical variables to construct predictive models. The anticipated results include a higher rate of complicated course in non-responders compared to responders, as well as potential differences in complicated course based on race/ethnicity. The study highlights the need for real-time prediction models to improve resuscitation for critically ill children. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
24. A0760 - Safety and tolerability of single-j vs. double-j stents after ureterorenoscopy – a randomized trial.
- Author
-
Laranjo Tinoco, C., Martins, L., Cardoso, A., Araújo, A.S., Capinha, M., Pinto, L., Coutinho, A., Rodrigues, R., Anacleto, S., Ribeiro, J., Carvalho-Dias, E., Mendes, M., Marques, V., Pimentel Torres, J., Oliveira, C., Alves, M., and Mota, P.
- Subjects
- *
URETEROSCOPY , *SAFETY - Published
- 2024
- Full Text
- View/download PDF
25. Immunoinformatic approaches for ErpY-LemA chimeric protein design for use in leptospirosis control.
- Author
-
Ávila-Martínez EG, Cardoso TL, Pereira IL, Caballero PS, Wozeak DR, Neto ACPS, da Silva Pinto L, and Hartwig DD
- Abstract
Aims: Currently, immunoinformatic approaches have shown promise in rapidly and cost-effectively identifying new antigens from the Leptospira proteome. Chimeric multiepitope proteins offer a strategy with significant potential for implementation in serology and the design of effective vaccines., Methods and Results: In this study, we detail the immunoinformatic analyses and design of a new recombinant chimeric protein constructed with epitopes identified from the sequences of ErpY-like and LemA proteins, previously identified as potential antigens for controlling leptospirosis. We expressed the chimeric protein using Escherichia coli heterologous systems, evaluated its antigenicity using serum from naturally infected patients, and its immunogenicity in mice as an animal model, with Freund as an adjuvant. The resulting recombinant chimeric protein, named rErpY-LemA, was successfully expressed and purified using a prokaryotic system, with an expected mass of 35 kDa. Serologic assays using serum samples from naturally infected patients demonstrated recognition of the chimera protein by antibodies present in sera. Animals immunized with the chimera exhibited a significant IgG antibody response from the 7th day (P<0.001), persisting until day 49 of experimentation, with a titer of 1:12,800 (P<0.05). Notably, significant production of IgA, IgM, and IgG subclasses was observed in animals immunized with the chimera., Conclusions: These results highlight the promising role of immunoinformatics in rapidly identifying antigens and the potential of chimeric multiepitope proteins in developing effective strategies for leptospirosis control., (© The Author(s) 2024. Published by Oxford University Press on behalf of Applied Microbiology International.)
- Published
- 2024
- Full Text
- View/download PDF
26. Midterm Survival Results of Preserflo® in a Real-world Setting: A Retrospective 2-year Analysis.
- Author
-
Lima-Cabrita A, Santos M, José P, Barão R, Barata A, and Abegão Pinto L
- Abstract
Prcis: Preserflo® surgery is a safe procedure, effective in reducing intraocular pressure into the "low teens", surgical survival is greatest in cases of high baseline intraocular pressure (above 21 mmHg) and when performed as a standalone procedure., Purpose: To evaluate midterm surgical survival and safety profile of Preserflo® filtering surgery., Methods: Retrospective, cohort study. Consecutive patients who underwent standardized Preserflo® implantation with mitomycin C from December 2019 to April 2021 were included. Clinical data was retrieved from patient charts. Primary outcome was surgical survival at twenty-four months in accordance with World Glaucoma Association guidelines. Survival was evaluated using Kaplan-Meier statistics. Analysis was performed at eye-level and as intention-to-treat., Results: Ninety-five eyes were included in this study (18 cases combined with cataract surgery). Over half of cases (n=51) were primary open angle glaucoma, with over a fifth having a prior filtering glaucoma procedure. Intraocular pressure at twenty-four months was significantly decreased from baseline (22.4±6.28 mmHg vs 12.0±3.43 mmHg), as well as the need for IOP-lowering medication (2.88 (±0.92) vs 0.79 (±1.3), P<0.001 all comparisons. Standalone Preserflo® achieved a qualified survival (irrespective of medication) of 71% (CI 95% 62%-83%) and 44% (CI 95% 27%-75%) in the combined procedure subgroup (P<0.05 when considering absolute survival). Eyes with baseline intraocular pressure ≥21 mmHg showed a greater qualified survival when compared to eyes with baseline ≤18 mmHg (80% (CI 95% 65%-100%) vs (50% (CI 95% 32%-76%; P<0.05). Intra and early operative complications were few, self-limited, and did not require surgical management. The reoperation rate was low (18%)., Conclusion: Preserflo ® filtering surgery is effective in reducing intraocular pressure into the "low teens" and presents an adequate surgical survival and safety profile. Surgical survival appears greatest when performed as standalone and when pre-operative intraocular pressure is high (≥21 mmHg)., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
27. Identification and transcriptomic assessment of latent profile pediatric septic shock phenotypes.
- Author
-
Atreya MR, Huang M, Moore AR, Zheng H, Hasin-Brumshtein Y, Fitzgerald JC, Weiss SL, Cvijanovich NZ, Bigham MT, Jain PN, Schwarz AJ, Lutfi R, Nowak J, Thomas NJ, Quasney M, Dahmer MK, Baines T, Haileselassie B, Lautz AJ, Stanski NL, Standage SW, Kaplan JM, Zingarelli B, Sahay R, Zhang B, Sweeney TE, Khatri P, Sanchez-Pinto LN, and Kamaleswaran R
- Subjects
- Humans, Female, Male, Child, Child, Preschool, Prospective Studies, Infant, Transcriptome genetics, Gene Expression Profiling methods, Adolescent, Cohort Studies, Biomarkers analysis, Shock, Septic genetics, Shock, Septic classification, Shock, Septic physiopathology, Phenotype
- Abstract
Background: Sepsis poses a grave threat, especially among children, but treatments are limited owing to heterogeneity among patients. We sought to test the clinical and biological relevance of pediatric septic shock subclasses identified using reproducible approaches., Methods: We performed latent profile analyses using clinical, laboratory, and biomarker data from a prospective multi-center pediatric septic shock observational cohort to derive phenotypes and trained a support vector machine model to assign phenotypes in an internal validation set. We established the clinical relevance of phenotypes and tested for their interaction with common sepsis treatments on patient outcomes. We conducted transcriptomic analyses to delineate phenotype-specific biology and inferred underlying cell subpopulations. Finally, we compared whether latent profile phenotypes overlapped with established gene-expression endotypes and compared survival among patients based on an integrated subclassification scheme., Results: Among 1071 pediatric septic shock patients requiring vasoactive support on day 1 included, we identified two phenotypes which we designated as Phenotype 1 (19.5%) and Phenotype 2 (80.5%). Membership in Phenotype 1 was associated with ~ fourfold adjusted odds of complicated course relative to Phenotype 2. Patients belonging to Phenotype 1 were characterized by relatively higher Angiopoietin-2/Tie-2 ratio, Angiopoietin-2, soluble thrombomodulin (sTM), interleukin 8 (IL-8), and intercellular adhesion molecule 1 (ICAM-1) and lower Tie-2 and Angiopoietin-1 concentrations compared to Phenotype 2. We did not identify significant interactions between phenotypes, common treatments, and clinical outcomes. Transcriptomic analysis revealed overexpression of genes implicated in the innate immune response and driven primarily by developing neutrophils among patients designated as Phenotype 1. There was no statistically significant overlap between established gene-expression endotypes, reflective of the host adaptive response, and the newly derived phenotypes, reflective of the host innate response including microvascular endothelial dysfunction. However, an integrated subclassification scheme demonstrated varying survival probabilities when comparing patient endophenotypes., Conclusions: Our research underscores the reproducibility of latent profile analyses to identify pediatric septic shock phenotypes with high prognostic relevance. Pending validation, an integrated subclassification scheme, reflective of the different facets of the host response, holds promise to inform targeted intervention among those critically ill., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
28. Corrigendum to "Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions" [International Journal of Antimicrobial Agents Volume 63, Issue 5 (2024) 107150].
- Author
-
Blanco-Martín T, Alonso-García I, González-Pinto L, Outeda-García M, Guijarro-Sánchez P, López-Hernández I, Pérez-Vázquez M, Aracil B, López-Cerero L, Fraile-Ribot P, Oliver A, Vázquez-Ucha JC, Beceiro A, Bou G, and Arca-Suárez J
- Published
- 2024
- Full Text
- View/download PDF
29. Impact of a regional simulation-based training course in the implementation of external cephalic version: Intervention study.
- Author
-
Pinto L, Fonseca A, and Ayres-de-Campos D
- Abstract
Objective: The aims of this study were to assess whether a regional simulation-based training course in external cephalic version (ECV) would lead to the adoption of this technique in hospitals where it was not previously practiced, and to improve success rates in those already performing it., Methods: This was an intervention study where two specialists in obstetrics and gynecology from 10 Portuguese public maternity hospitals attended a structured simulation-based training in ECV. Hospitals were categorized based on whether ECV was conducted prior to the training program, and on their annual number of deliveries. Main outcomes were the number of ECVs performed in the 2 years before and after the course, and their success rates., Results: Implementation of ECV was achieved in four additional hospitals during the 2 years following the course. Among the three hospitals already performing ECV and able to report their data, no significant differences in success rates were observed in the 2 years following the course (45.6% vs. 47.9%, P = 0.797). After a successful ECV, 77.7% of women had a vaginal delivery., Conclusion: A regional simulation-based training course in ECV led to an increase in the number of hospitals implementing the technique in the subsequent 2 years, but it did not impact the success rates in centers where it was already performed. This study highlights the potential of simulation-based courses in ECV, as well as the need to improve patients´ access to the technique and to centralize ECV services at a regional level., (© 2024 International Federation of Gynecology and Obstetrics.)
- Published
- 2024
- Full Text
- View/download PDF
30. Patient-derived induced pluripotent stem cells: Tools to advance the understanding and drug discovery in Major Depressive Disorder.
- Author
-
Vaz A, Salgado A, Patrício P, and Pinto L
- Abstract
Major Depressive Disorder (MDD) is a pleomorphic disease with substantial patterns of symptoms and severity with mensurable deficits in several associated domains. The broad spectrum of phenotypes observed in patients diagnosed with depressive disorders is the reflection of a very complex disease where clusters of biological and external factors (e.g., response/processing of life events, intrapsychic factors) converge and mediate pathogenesis, clinical presentation/phenotypes and trajectory. Patient-derived induced pluripotent stem cells (iPSCs) enable their differentiation into specialised cell types in the central nervous system to explore the pathophysiological substrates of MDD. These models may complement animal models to advance drug discovery and identify therapeutic approaches, such as cell therapy, drug repurposing, and elucidation of drug metabolism, toxicity, and mechanisms of action at the molecular/cellular level, to pave the way for precision psychiatry. Despite the remarkable scientific and clinical progress made over the last few decades, the disease is still poorly understood, the incidence and prevalence continue to increase, and more research is needed to meet clinical demands. This review aims to summarise and provide a critical overview of the research conducted thus far using patient-derived iPSCs for the modelling of psychiatric disorders, with a particular emphasis on MDD., Competing Interests: Declaration of competing interest The authors unequivocally declare that they have no conflicts of interest and assume full responsibility for ensuring the reliability and impartiality of the scientific content of this article., (Copyright © 2024. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
31. phoenix: an R package and Python module for calculating the Phoenix pediatric sepsis score and criteria.
- Author
-
DeWitt PE, Russell S, Rebull MN, Sanchez-Pinto LN, and Bennett TD
- Abstract
Objectives: The publication of the Phoenix criteria for pediatric sepsis and septic shock initiates a new era in clinical care and research of pediatric sepsis. Tools to consistently and accurately apply the Phoenix criteria to electronic health records (EHRs) is one part of building a robust and internally consistent body of research across multiple research groups and datasets., Materials and Methods: We developed the phoenix R package and Python module to provide researchers with intuitive and simple functions to apply the Phoenix criteria to EHR data., Results: The phoenix R package and Python module enable researchers to apply the Phoenix criteria to EHR datasets and derive the relevant indicators, total scores, and sub-scores., Discussion: The transition to the Phoenix criteria marks a major change in the conceptual definition of pediatric sepsis. Applicable across differentially resourced settings, the Phoenix criteria should help improve clinical care and research., Conclusion: The phoenix R package and Python model are freely available on CRAN, PyPi, and GitHub. These tools enable the consistent and accurate application of the Phoenix criteria to EHR datasets., Competing Interests: None declared., (© The Author(s) 2024. Published by Oxford University Press on behalf of the American Medical Informatics Association.)
- Published
- 2024
- Full Text
- View/download PDF
32. Liquid-Liquid Equilibrium of Sesame Fatty Acid (Ethyl and Methyl) Ester + Glycerol + Ethanol/Methanol Mixtures at Different Temperatures.
- Author
-
Silva A, Lopes G, Corazza M, Arce P, Coêlho D, Meili L, Carvalho S, Ferreira-Pinto L, and Soletti J
- Abstract
This study aimed to investigate the liquid-liquid equilibrium (LLE) behavior of sesame fatty acid ethyl ester (FAEE) and methyl ester (FAME) in combination with glycerol and the co-solvents ethanol and methanol. FAEE and FAME were produced through the transesterification of mechanically extracted and purified sesame oil, using potassium hydroxide (KOH) as a homogeneous base catalyst. The reactions were conducted in ethanol and methanol to produce FAEE and FAME, respectively. Post-reaction, the products were separated and purified, followed by an analysis of the LLE behavior at 313.15 K and 323.15 K under atmospheric pressure (101.3 kPa). The experimental process for the miscibility analysis utilized a jacketed glass cell adapted for this study. Miscibility limits or binodal curves were determined using the turbidity-point method. Tie lines were constructed by preparing mixtures of known concentrations within the two-phase region, which allowed the phases to separate after agitation. Samples from both phases were analyzed to determine their composition. This study revealed that higher temperatures promoted greater phase separation and enhanced the biodiesel purification process. The NRTL model effectively correlated the activity coefficients with the experimental data, showing good agreement, with a root-mean-square deviation of 3.5%. Additionally, the data quality was validated using Marcilla's method, which yielded an R
2 value close to 1. Attraction factors and distribution coefficients were also calculated to evaluate the efficiency of the co-solvents as extraction agents. The findings indicated higher selectivity for methanol than for ethanol, with varying degrees of distribution among the co-solvents. These results offer significant insights into enhancing biodiesel production processes by considering the effects of co-solvents on the LLE properties of mixtures, ultimately contributing to more efficient and cost-effective biodiesel production.- Published
- 2024
- Full Text
- View/download PDF
33. Dimensions of Arachnoid Bulk Ratio: A Superior Optic Nerve Sheath Index for Intracranial Pressure.
- Author
-
Berhanu D, Carneiro I, Antunes AP, Abegão Pinto L, Fragata I, Tavares Ferreira J, and Lucas Neto L
- Subjects
- Humans, Female, Male, Adult, Prospective Studies, Ultrasonography methods, Middle Aged, Optic Nerve diagnostic imaging, Intracranial Pressure physiology, Intracranial Hypertension diagnostic imaging, Intracranial Hypertension physiopathology, Arachnoid diagnostic imaging
- Abstract
Background Discrepancies in the literature regarding optimal optic nerve sheath diameter (ONSD) cutoffs for intracranial pressure (ICP) necessitate alternative neuroimaging parameters to improve clinical management. Purpose To evaluate the diagnostic accuracy of the dimensions of the perineural subarachnoid space to the optic nerve sheath ratio, measured using US, in predicting increased ICP. Materials and Methods In a prospective cohort study from April 2022 to December 2023, patients with suspected increased ICP underwent optic nerve US to determine the dimensions of arachnoid bulk (DAB) ratio and ONSD before invasive ICP measurement. Correlation between the parameters and ICP, as well as diagnostic accuracy, was assessed using area under the receiver operating characteristic curve (AUC) analysis. Results A total of 30 participants were included (mean age, 39 years ± 14 [SD]; 24 female). The DAB ratio and ONSD were significantly larger in participants with increased ICP (38% [0.16 of 0.42] and 14% [0.82 of 6.04 mm], respectively; P < .001). The DAB ratio showed a stronger correlation with ICP than ONSD ( r
s = 0.87 [ P < .001] vs rs = 0.61 [ P < .001]). The DAB ratio and ONSD optimal cutoffs for increased ICP were 0.5 and 6.5 mm, respectively, and the ratio had higher sensitivity (100% vs 92%) and specificity (94% vs 83%) compared with ONSD. Moreover, the DAB ratio better predicted increased ICP than ONSD, with a higher AUC (0.98 [95% CI: 0.95, 1.00] vs 0.86 [95% CI: 0.71, 0.95], P = .047). Conclusion An imaging ratio was proposed to predict ICP based on the relative anatomy of the cerebrospinal fluid space, demonstrating more accurate diagnosis of increased ICP and a strong correlation with ICP values, suggesting its potential utility as a neuroimaging marker in clinical settings. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Shepherd in this issue.- Published
- 2024
- Full Text
- View/download PDF
34. Antibodies anti-rFilF protein has anti-biofilm activity against carbapenem-resistant Acinetobacter baumannii.
- Author
-
Pereira IL, Cardoso TL, Wozeak DR, Caballero PS, Buchhorn de Freitas S, Pinto Seixas Neto AC, da Silva Pinto L, and Hartwig DD
- Subjects
- Animals, Mice, Immunoglobulin G immunology, Anti-Bacterial Agents pharmacology, Acinetobacter Infections immunology, Acinetobacter Infections microbiology, Recombinant Proteins immunology, Recombinant Proteins pharmacology, Recombinant Proteins genetics, Mice, Inbred BALB C, Female, Escherichia coli genetics, Escherichia coli immunology, Bacterial Outer Membrane Proteins immunology, Bacterial Outer Membrane Proteins genetics, Biofilms drug effects, Acinetobacter baumannii immunology, Acinetobacter baumannii drug effects, Antibodies, Bacterial immunology, Carbapenems pharmacology
- Abstract
Acinetobacter baumannii is an opportunistic bacterium that causes infection in several sites. Carbapenem-resistant A. baumannii strains (CRAb) lead the World Health Organization's list of 12 pathogens considered a priority for developing new antimicrobials. The pathogenicity of A. baumannii is related to the different virulence factors employed in the colonization of biotic and abiotic surfaces, biofilm formation and multidrug resistance. We analyze the outer membrane protein FilF from A. baumannii in silico and produce it in recombinant form (rFilF). rFilF protein was successfully expressed in Escherichia coli BL21 Star in an insoluble form. Immunization with rFilF induced significant anti-rFilF IgG antibody production in mice, detected by indirect enzyme-linked immunosorbent assay, since the first evaluation until 49th. On the last experimentation day, the predominant immunoglobulin found was IgG1 followed by IgG2a, IgG2b, IgM, IgG3, and IgA. We observe that interleukins 4 and 10 show significant production after the 28th day of experimentation in mice immunized with rFilF. Anti-rFilF pAbs were able to inhibit biofilm formation in nine CRAb strains evaluated, and in the standard strain ATCC® 19606. These results demonstrate the anti-biofilm activity of anti-rFilF antibodies, promising in the development of a non-antibiotic approach based on the control of CRAb strains., Competing Interests: Declaration of competing interest The authors declare no conflict of interest. The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results., (Copyright © 2024 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
35. Evaluation and validation of a PrintrLab-based LAMP assay to identify Trypanosoma cruzi in newborns in Bolivia: a proof-of-concept study.
- Author
-
Rojas Panozo L, Rivera Nina S, Wehrendt DP, Casellas A, Pinto L, Mendez S, Kuo CW, Lozano DF, Ortiz L, Pinazo MJ, Picado A, Sanz S, Abril M, Gascon J, Wong S, Schijman AG, Torrico F, and Alonso-Padilla J
- Abstract
Background: Vertical transmission of Trypanosoma cruzi represents approximately 20% of new Chagas disease cases. Early detection and treatment for women of childbearing age and newborns is a public health priority, but the lack of a simple and reliable diagnostic test remains a major barrier. We aimed to evaluate the performance of a point-of-care loop-mediated isothermal amplification (LAMP) assay for the detection of T cruzi., Methods: In this proof-of-concept study, we coupled a low-cost 3D printer repurposed for sample preparation and amplification (PrintrLab) to the Eiken T cruzi-LAMP prototype to detect vertically transmitted T cruzi, which we compared with standardised PCR and with the gold-standard algorithm (microscopy at birth and 2 months and serological study several months later). We screened pregnant women from two hospitals in the Bolivian Gran Chaco province, and those who were seropositive for T cruzi were offered the opportunity for their newborns to be enrolled in the study. Newborns were tested by microscopy, LAMP, and PCR at birth and 2 months, and by serology at 8 months., Findings: Between April 23 and Nov 17, 2018, 986 mothers were screened, among whom 276 were seropositive for T cruzi (28·0% prevalence, 95% CI 25·6-31·2). In total, 224 infants born to 221 seropositive mothers completed 8 months of follow-up. Congenital transmission was detected in nine of the 224 newborns (4·0% prevalence, 1·9-7·5) by direct microscopy observation, and 14 more cases were diagnosed serologically (6·3%, 3·6-10·3), accounting for an overall vertical transmission rate of 10·3% (6·6-15·0; 23 of 224). All microscopy-positive newborns were positive by PrintrLab-LAMP and by PCR, while these techniques respectively detected four and five extra positive cases among the remaining 215 microscopy-negative newborns., Interpretation: The PrintrLab-LAMP yielded a higher sensitivity than microscopy-based analysis. Considering the simpler use and expected lower cost of LAMP compared with PCR, our findings encourage its evaluation in a larger study over a wider geographical area., Funding: Inter-American Development Bank., Competing Interests: Declaration of interests C-WK and SW are employees at AI Biosciences, the biotechnology company that developed the PrintrLab. All other authors declare no competing interests., (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
36. In defence of the entity of Macaronesia as a biogeographical region.
- Author
-
Fernández-Palacios JM, Otto R, Capelo J, Caujapé-Castells J, de Nascimento L, Duarte MC, Elias RB, García-Verdugo C, Menezes de Sequeira M, Médail F, Naranjo-Cigala A, Patiño J, Price J, Romeiras MM, Sánchez-Pinto L, and Whittaker RJ
- Abstract
Since its coinage ca. 1850 AD by Philip Barker Webb, the biogeographical region of Macaronesia, consisting of the North Atlantic volcanic archipelagos of the Azores, Madeira with the tiny Selvagens, the Canaries and Cabo Verde, and for some authors different continental coastal strips, has been under dispute. Herein, after a brief introduction on the terminology and purpose of regionalism, we recover the origins of the Macaronesia name, concept and geographical adscription, as well as its biogeographical implications and how different authors have positioned themselves, using distinct terrestrial or marine floristic and/or faunistic taxa distributions and relationships for accepting or rejecting the existence of this biogeographical region. Four main issues related to Macaronesia are thoroughly discussed: (i) its independence from the Mediterranean phytogeographical region; (ii) discrepancies according to different taxa analysed; (iii) its geographical limits and the role of the continental enclave(s), and, (iv) the validity of the phytogeographical region level. We conclude that Macaronesia has its own identity and a sound phytogeographical foundation, and that this is mainly based on three different floristic components that are shared by the Macaronesian core (Madeira and the Canaries) and the outermost archipelagos (Azores and Cabo Verde). These floristic components are: (i) the Palaeotropical-Tethyan Geoflora, formerly much more widely distributed in Europe and North Africa and currently restricted to the three northern archipelagos (the Azores, Madeira and the Canaries); (ii) the African Rand Flora, still extant in the coastal margins of Africa and Arabia, and present in the southern archipelagos (Madeira, the Canaries and Cabo Verde), and (iii) the Macaronesian neoendemic floristic component, represented in all the archipelagos, a result of allopatric diversification promoted by isolation of Mediterranean ancestors that manage to colonize Central Macaronesia and, from there, the outer archipelagos. Finally, a differentiating floristic component recently colonized the different archipelagos from the nearest continental coast, providing them with different biogeographic flavours., (© 2024 The Author(s). Biological Reviews published by John Wiley & Sons Ltd on behalf of Cambridge Philosophical Society.)
- Published
- 2024
- Full Text
- View/download PDF
37. Molecular frequency of bovine leukemia virus in Creole cattle of Eastern Colombia.
- Author
-
Jaimes-Dueñez J, Goyeneche-Ortiz E, Tique-Oviedo M, Ortiz-Pineda MC, Cardenas-Pinto L, Jimenez-Leaño AP, and Ruiz-Saenz J
- Abstract
Enzootic Bovine Leukosis (EBL), caused by the bovine leukosis virus (BLV), is a global infectious disease affecting livestock. This study focuses on studying the frequency and genetic traits of BLV in three Creole breeds including Chino Santandereano (Chino), Casanareño (CAS), and Sanmartinero (SM) in Eastern Colombia. We implemented a cross-sectional survey between 2019 and 2020 across four departments (Arauca, Casanare, Santander and Meta) in Eastern Colombia to assess the molecular characteristics of BLV infection in these breeds. A total of 253 cattle were analyzed, of which 42.6 %, 28.8 %, and 28.4 % belonged to the Chino, CAS, and SM breeds, respectively. BLV provirus was detected using nested polymerase chain reaction (n-PCR) targeting the conserved region of the env viral gene. Subsequently, the obtained amplicons were sequenced and subjected to phylogenetic analyses. The overall BLV infection frequency was 26.48 % (95 % CI: 21.01 - 31.98 %), with Chino exhibiting the highest frequency (35.1 %) following by SAM and CAS, respectively ( P < 0.05). Other epidemiological variables associated with the infection included age, department, and season ( P < 0.05). BLV-positive animals exhibited elevated levels of total serum proteins ( P < 0.05), while molecular characterization revealed the exclusive circulation of BLV genotype 1 within these breeds. This study provides an updated assessment of BLV infection in Creole breeds from the eastern of Colombia, underscoring their lower infection frequency compared to introduced breeds and their reduced susceptibility to developing clinical signs. The epidemiological and molecular characteristics observed should be considered in developing control programs aimed at improving genetic resistance to BLV in Colombian cattle., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 Universidad Cooperativa de Colombia.)
- Published
- 2024
- Full Text
- View/download PDF
38. Estimating prevalence of classical homocystinuria in the United States using Optum's de-identified market clarity data.
- Author
-
Jain M, Shah M, Thakker KM, Rava A, Block AP, Ndiba-Markey C, and Pinto L
- Abstract
Background and Objectives: Prevalence estimates for classical homocystinuria (HCU) are variable and likely underestimated due to underdiagnosis. Claims data represent a strong but seldom used resource to analyze prevalence of HCU. The aim of this study was to estimate a prevalence range of HCU in the US utilizing a combination of diagnosis codes, total homocysteine levels, and clinical presentations indicative of HCU., Methods: This was a non-interventional retrospective cohort study, using Optum's de-identified Market Clarity Data, with a patient identification period from January 01, 2016, through September 30, 2021. An algorithm was developed to identify 2 cohorts of patients using broad and strict definitions of HCU. The index date was the date within the identification period on which the first criterion was met for the inclusion criteria. Baseline demographics, clinical characteristics, and complications were assessed and summarized using descriptive statistics. Crude and standardized prevalence estimates were calculated., Results: There were 3880 and 633 patients that met the relevant inclusion criteria for the broad and strict cohorts, respectively. The projected US prevalence of HCU was calculated to be 17,631 and 3466 based on the broad and strict definitions, respectively. The average annual standardized prevalence across 2016-2020 was 5.29 and 1.04 per 100,000 people for the broad and strict cohorts, respectively., Conclusions: Prevalence estimates of HCU vary depending on databases or datasets used and identification criteria. Many patients with clinical presentations suggesting a diagnosis of HCU did not have an associated diagnosis, potentially indicating underdiagnosis or underreporting. Future research should study alternative methods, such as the identification algorithm in our analysis, to better diagnose and understand the true prevalence of HCU., Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests. Mahim Jain reports financial support was provided by Travere Therapeutics Inc. Kamlesh M. Thakker reports financial support was provided by Travere Therapeutics Inc. Mehul Shah reports a relationship with Travere Therapeutics Inc. that includes: employment and equity or stocks. Agness Pelts Block reports a relationship with Travere Therapeutics Inc. that includes: employment and equity or stocks. Lionel Pinto reports a relationship with Travere Therapeutics Inc. that includes: employment and equity or stocks. Andrew Rava and Colette Ndiba-Markey are employees of Genesis Research Group, which receives consulting fees from Travere Therapeutics, Inc. for this study and other related studies. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. M.J. has received consultancy fees from Travere Therapeutics, Inc. M.S. is an employee and stock/options holder (vested and unvested) of Travere Therapeutics, Inc. K.M.T has a consulting contract with Travere Therapeutics, Inc. and does not have any equity interest in Travere Therapeutics, Inc. A.R. is an employee of Genesis Research Group, which receives consulting fees from Travere Therapeutics, Inc. for this study and other related studies. A.P.B. is an employee and stockholder of Travere Therapeutics Inc. C.N.M. is an employee of Genesis Research Group, which receives consulting fees from Travere Therapeutics, Inc. for this study and other related studies. L.P. is a former employee and stock/options holder (vested and unvested) of Travere Therapeutics, Inc., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
39. Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome.
- Author
-
Song Y, Loomans-Kropp H, Baugher RN, Somerville B, Baxter SS, Kerr TD, Plona TM, Mellott SD, Young TB, Lawhorn HE, Wei L, Hu Q, Liu S, Hutson A, Pinto L, Potter JD, Sei S, Gelincik O, Lipkin SM, Gebert J, Kloor M, and Shoemaker RH
- Subjects
- Humans, Male, Female, Middle Aged, Adult, Aged, DNA Mismatch Repair genetics, High-Throughput Nucleotide Sequencing, ROC Curve, Case-Control Studies, Sensitivity and Specificity, Frameshift Mutation, Colorectal Neoplasms, Hereditary Nonpolyposis genetics, Colorectal Neoplasms, Hereditary Nonpolyposis diagnosis, Colorectal Neoplasms, Hereditary Nonpolyposis blood, Biomarkers, Tumor blood, Biomarkers, Tumor genetics, Microsatellite Instability
- Abstract
Background: Lynch syndrome is a hereditary cancer predisposition syndrome caused by germline mutations in DNA mismatch repair genes, which lead to high microsatellite instability and frameshift mutations at coding mononucleotide repeats in the genome. Recurrent frameshift mutations in these regions are thought to play a central role in the increased risk of various cancers, but no biomarkers are currently available for the surveillance of high microsatellite instability-associated cancers., Methods: A frameshift mutation-based biomarker panel was developed and validated by targeted next-generation sequencing of supernatant DNA from cultured high microsatellite instability colorectal cancer cells. This panel supported selection of 122 frameshift mutation targets as potential biomarkers. This biomarker panel was then tested using matched tumor, adjacent normal tissue, and buffy coat samples (53 samples) and blood-derived cell-free DNA (cfDNA) (38 samples) obtained from 45 high microsatellite instability and mismatch repair-deficient patients. We also sequenced cfDNA from 84 healthy participants to assess background noise., Results: Recurrent frameshift mutations at coding mononucleotide repeats were detectable not only in tumors but also in cfDNA from high microsatellite instability and mismatch repair-deficient patients, including a Lynch syndrome carrier, with a varying range of target detection (up to 85.2%), whereas they were virtually undetectable in healthy participants. Receiver operating characteristic curve analysis showed high sensitivity and specificity (area under the curve = 0.94) of the investigated panel., Conclusions: We demonstrated that frameshift mutations can be detected in cfDNA from high microsatellite instability and mismatch repair-deficient patients and asymptomatic carriers. The 122-target frameshift mutation panel described here has promise as a tool for improved surveillance of high microsatellite instability and mismatch repair-deficient patients, with the potential to reduce the frequency of invasive screening methods for this high-cancer-risk cohort., (Published by Oxford University Press 2024.)
- Published
- 2024
- Full Text
- View/download PDF
40. 'Wet purpura'-a sign of immune thrombocytopenia.
- Author
-
Bezerra Machado AI, Vieira Fernandes I, Araújo M, and Pinto L
- Published
- 2024
- Full Text
- View/download PDF
41. Assessing Different Histological Preparations for Reconstruction of Astrocyte Tridimensional Structure.
- Author
-
Barsanti S, Viana JF, Veiga A, Machado JL, Abreu DS, Dias JD, Monteiro S, Silva NA, Pinto L, and Oliveira JF
- Subjects
- Animals, Mice, Hippocampus cytology, Glial Fibrillary Acidic Protein metabolism, Mice, Inbred C57BL, Male, Staining and Labeling methods, Astrocytes metabolism, Astrocytes cytology
- Abstract
Astrocytes are ubiquitous in the brain and spinal cord and display a complex morphology important for the local interactions with neighboring cells, resulting in the modulation of circuit function. Thus, studies focusing on astrocyte physiology in the healthy and diseased brain generally present analyses of astrocytic structure. The labeling method used to visualize the astrocytic structure defines the morphological level to observe and may vary depending on the anatomical sub-regions. The method choice may significantly affect our understanding of their structural diversity. The main goal of this work was to identify a straightforward and efficient protocol for labeling and reconstructing a detailed astrocytic structure to apply and validate in different brain tissue preparations across laboratories. For that, we explored different tissue processing protocols before GFAP labeling to determine the most effective method for reconstructing astrocytic backbones in the mouse hippocampus. Our results show that the reconstruction of astrocytic structure in vibratome sections labeled by free-floating immunofluorescence protocol provides a more practical method to achieve a higher level of detail and arbor complexity in astrocyte backbone reconstruction. Free-floating immunofluorescence labeling is the most reliable method for obtaining better antibody penetration and more detailed astrocyte structure. Finally, we also show that introducing an antigen retrieval step appears useful for visualizing more complete structural details.
- Published
- 2024
- Full Text
- View/download PDF
42. Effects of bioconversion by Battus polydamas on the chemical composition of Aristolochia spp. and evaluation of antimicrobial activity and biocompatibility.
- Author
-
do Prado Schneidewind FCC, de Castilho PF, Galvão F, de Andrade Dos Santos JV, da Silva Dantas FG, Negri M, da Silva Pinto L, Moraes CAF, Freitas J, de Souza PRB, Nogueira CR, and de Oliveira KMP
- Subjects
- Animals, Larva drug effects, Phytochemicals pharmacology, Phytochemicals isolation & purification, Microbial Sensitivity Tests, Humans, Antioxidants pharmacology, Bacillus cereus drug effects, Anti-Infective Agents pharmacology, Anti-Infective Agents chemistry, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents chemistry, Moths drug effects, Aristolochia chemistry, Plant Extracts pharmacology, Plant Extracts chemistry
- Abstract
Aristolochia plants are emblematic from an ethnopharmacological viewpoint and are know to possess numerous biological properties, including antiseptic. However, the medicinal potential of these species is debatable because of their representative chemical constituents, aristolochic acids (AAs) and aristolactams (ALs), which are associated, for instance, with nephropathy and cancer. These contrasting issues have stimulated the development of approaches intended to detoxification of aristoloquiaceous biomasses, among which is included the bioconversion method using larvae of the specialist phytophagous insect Battus polydamas, previously shown to be viable for chemical diversification and to reduce toxicity. Thus, eleven Aristolochia spp. were bioconverted, and the antimicrobial activities of the plant methanolic extracts and its respective bioconversion products were evaluated. The best results were found for Aristolochia esperanzae, Aristolochia gibertii, and Aristolochia ringens against Bacillus cereus, with MIC ranging from 7.8 to 31.25 μg/mL. These three species were selected for chemical, antioxidant, cytotoxic, hemolytic, and mutagenic analyses. Chemical analysis revealed 65 compounds, 21 of them possible bioconversion products. The extracts showed potential to inhibit the formation and degradation of B. cereus biofilms. Extracts of A. gibertii and its bioconverted biomass showed antioxidant activity comparable to dibutylhydroxytoluene (BHT) standard. Bioconversion decreased the hemolytic activity of A. esperanzae and the cytotoxicities of A. esperanzae and A. gibertii. None of the extracts was found to be mutagenic. The bioactivities of the fecal extracts were maintained, and biocompatibility was improved. Therefore, the results obtained in this study reveal positive expectations about the natural detoxification process of the Aristolochia species., Competing Interests: Declaration of competing interest The authors declare no conflict of interest., (Copyright © 2023. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
43. Additional Guidance on the Use of the PRESERFLO™ MicroShunt in the Treatment of Glaucoma: Insights from a Second Delphi Consensus Panel.
- Author
-
Khawaja AP, Abegão Pinto L, Stalmans I, Aptel F, Barkander A, Barton K, Beckers H, Iliev M, Klink T, Marchini G, Martínez de la Casa J, Pillunat KR, Simonsen JH, and Vass C
- Abstract
Introduction: The PRESERFLO™ MicroShunt (PMS) has been proven to significantly lower intraocular pressure (IOP) in patients with glaucoma and has been available for use since 2019. With increasing published evidence and growing experience of glaucoma surgeons, the aim of this modified Delphi panel was to build on the findings of a previous Delphi panel conducted in 2021 and provide further guidance on the role of the PMS to treat patients with glaucoma in Europe., Methods: Thirteen European glaucoma surgeons experienced in the PMS procedure participated in a 3-round modified Delphi panel. A targeted literature review and expert steering committee guided Round 1 questionnaire development. Consensus was pre-defined at a threshold of ≥ 70% of panellists selecting 'strongly agree'/'agree' or 'strongly disagree'/'disagree' for 6-point Likert scale questions or ≥ 70% selecting the same option for multiple or single-choice questions. Questions not reaching consensus were restated/revised for the next round, following guidance from free-text responses/scoping questions., Results: In total, 28% (n = 9/32), 52% (n = 16/31) and 91% (n = 10/11) of statements reached consensus in Rounds 1, 2 and 3, respectively. There was agreement that the PMS may be used in patients with pigmentary, post-trauma or post-vitrectomy glaucoma and for patients with uveitic glaucoma without active inflammation. The PMS may be more suitable for patients with contact lenses than other subconjunctival filtering surgeries, without eliminating bleb-associated risks. Consensus was reached that combining PMS implantation and phacoemulsification may be as safe as standalone PMS surgery, but further efficacy data are required. Following a late rise in IOP ≥ 4 months post-surgery, topical aqueous suppressant drops or bleb revision may be suitable management options., Conclusions: This Delphi panel builds on the considerations explored in the 2021 Delphi panel and provides further detailed guidance for glaucoma surgeons on the use of the PMS, reflecting the availability of novel evidence and surgical experience. Videos are available for this article., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
44. Treatment Outcomes Comparing the Paul and Baerveldt Glaucoma Implants After One Year of Follow-Up.
- Author
-
Berteloot S, Correia Barão R, Abegão Pinto L, Vandewalle E, Stalmans I, and Lemmens S
- Abstract
Prcis: In reducing intraocular pressure (IOP), Paul (PGI) and Baerveldt (BGI) glaucoma implants are safe and effective in patients with glaucoma., Objective: To compare efficacy and safety profiles of the PGI and BGI in the treatment of medically uncontrolled glaucoma at 1 year of follow-up., Methods: Retrospective analysis of patients implanted with a PGI or BGI with a minimum of 12 months follow-up. The primary outcome was surgical success defined as IOP ≥6 and ≤18 mm Hg and at least 20% IOP reduction from baseline. Secondary outcomes included IOP measurements, number of medications, and complications., Results: Twenty-three patients implanted with PGI and 27 with BGI were included. At last visit (12 mo), mean IOP had decreased from 23.7 ± 6.9 to 0.1 ± 2.9 mm Hg in the PGI group versus 26 ± 7.3 to 10.4 ± 4.9 mm Hg with the BGI ( P < 0.001 for both comparisons). Overall qualified success rates were similar between groups (PGI 91% vs BGI 89%, P = 0.784). IOP was significantly lower in the PGI at week 1 and month 1 of follow-up versus the BGI (13.6 ± 6.1 vs 20.1 ± 7.4; 14.6±3.8 vs 21.2 ± 5.8 mm Hg; P < 0.002 for both) with a lower number of medications (1.57 ± 1.47 vs 2.52 ± 1.16 at mo 1, P = 0.015). Most complications were minor and similar in both groups., Conclusion: Both PGI and BGI are safe and effective in reducing IOP in patients with glaucoma, with similar success rates., Competing Interests: Disclosure: The authors declare no conflict of interest., (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
45. Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions.
- Author
-
Blanco-Martín T, Alonso-García I, González-Pinto L, Outeda-García M, Guijarro-Sánchez P, López-Hernández I, Pérez-Vázquez M, Aracil B, López-Cerero L, Fraile-Ribot P, Oliver A, Vázquez-Ucha JC, Beceiro A, Bou G, and Arca-Suárez J
- Subjects
- Boronic Acids pharmacology, Meropenem pharmacology, Aztreonam pharmacology, Imipenem pharmacology, Bacterial Proteins genetics, Bacterial Proteins metabolism, Heterocyclic Compounds, 1-Ring pharmacology, Cell Membrane Permeability drug effects, Escherichia coli drug effects, Escherichia coli genetics, beta-Lactamases genetics, beta-Lactamases metabolism, Cephalosporins pharmacology, Microbial Sensitivity Tests, beta-Lactamase Inhibitors pharmacology, Azabicyclo Compounds pharmacology, Anti-Bacterial Agents pharmacology, Drug Combinations, Cyclooctanes pharmacology, Cefiderocol, Ceftazidime pharmacology, Cefepime pharmacology, Borinic Acids, Carboxylic Acids, Lactams, Triazoles
- Abstract
Objectives: To analyse the impact of the most clinically relevant β-lactamases and their interplay with low outer membrane permeability on the activity of cefiderocol, ceftazidime/avibactam, aztreonam/avibactam, cefepime/enmetazobactam, cefepime/taniborbactam, cefepime/zidebactam, imipenem/relebactam, meropenem/vaborbactam, meropenem/xeruborbactam and meropenem/nacubactam against recombinant Escherichia coli strains., Methods: We constructed 82 E. coli laboratory transformants expressing the main β-lactamases circulating in Enterobacterales (70 expressing single β-lactamase and 12 producing double carbapenemase) under high (E. coli TG1) and low (E. coli HB4) permeability conditions. Antimicrobial susceptibility testing was determined by reference broth microdilution., Results: Aztreonam/avibactam, cefepime/zidebactam, cefiderocol, meropenem/xeruborbactam and meropenem/nacubactam were active against all E. coli TG1 transformants. Imipenem/relebactam, meropenem/vaborbactam, cefepime/taniborbactam and cefepime/enmetazobactam were also highly active, but unstable against most of MBL-producing transformants. Combination of β-lactamases with porin deficiency (E. coli HB4) did not significantly affect the activity of aztreonam/avibactam, cefepime/zidebactam, cefiderocol or meropenem/nacubactam, but limited the effectiveness of the rest of carbapenem- and cefepime-based combinations. Double-carbapenemase production resulted in the loss of activity of most of the compounds tested, an effect particularly evident for those E. coli HB4 transformants in which MBLs were present., Conclusions: Our findings highlight the promising activity that cefiderocol and new β-lactam/β-lactamase inhibitors have against recombinant E. coli strains expressing widespread β-lactamases, including when these are combined with low permeability or other enzymes. Aztreonam/avibactam, cefiderocol, cefepime/zidebactam and meropenem/nacubactam will help to mitigate to some extent the urgency of new compounds able to resist MBL action, although NDM enzymes represent a growing challenge against which drug development efforts are still needed., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
46. Mechanistic Framework to Predict Maternal-Placental-Fetal Pharmacokinetics of Nifedipine Employing Physiologically Based Pharmacokinetic Modeling Approach.
- Author
-
Werdan Romão MA, Pinto L, Cavalli RC, Duarte G, de Moraes NV, Abduljalil K, and Moreira FL
- Subjects
- Humans, Pregnancy, Female, Caco-2 Cells, Fetus metabolism, Adult, Cytochrome P-450 CYP3A metabolism, Nifedipine pharmacokinetics, Nifedipine administration & dosage, Maternal-Fetal Exchange, Models, Biological, Placenta metabolism
- Abstract
Nifedipine is used for treating mild to severe hypertension and preventing preterm labor in pregnant women. Nevertheless, concerns about nifedipine fetal exposure and safety are always raised. The aim of this study was to develop and validate a maternal-placental-fetal nifedipine physiologically based pharmacokinetic (PBPK) model and apply the model to predict maternal, placental, and fetal exposure to nifedipine at different pregnancy stages. A nifedipine PBPK model was verified with nonpregnant data and extended to the pregnant population after the inclusion of the fetoplacental multicompartment model that accounts for the placental tissue and different fetal organs within the Simcyp Simulator version 22. Model parametrization involved scaling nifedipine transplacental clearance based on Caco-2 permeability, and fetal hepatic clearance was obtained from in vitro to in vivo extrapolation encompassing cytochrome P450 3A7 and 3A4 activities. Predicted concentration profiles were compared with in vivo observations and the transplacental transfer results were evaluated using 2-fold criteria. The PBPK model predicted a mean cord-to-maternal plasma ratio of 0.98 (range, 0.86-1.06) at term, which agrees with experimental observations of 0.78 (range, 0.59-0.93). Predicted nifedipine exposure was 1.4-, 2.0-, and 3.0-fold lower at 15, 27, and 39 weeks of gestation when compared with nonpregnant exposure, respectively. This innovative PBPK model can be applied to support maternal and fetal safety assessment for nifedipine at various stages of pregnancy., (© 2024, The American College of Clinical Pharmacology.)
- Published
- 2024
- Full Text
- View/download PDF
47. Extent of Virulence and Antibiotic Resistance Genes in Helicobacter pylori and Campylobacteria.
- Author
-
Rao RSP, Ghate SD, Pinto L, Suravajhala P, Patil P, Shetty P, and Ahsan N
- Subjects
- Virulence genetics, Bacterial Proteins genetics, Genome, Bacterial, Helicobacter Infections microbiology, Humans, Helicobacter pylori genetics, Helicobacter pylori drug effects, Helicobacter pylori pathogenicity, Drug Resistance, Bacterial genetics, Anti-Bacterial Agents pharmacology, Virulence Factors genetics
- Abstract
Helicobacter pylori, a member of the clade campylobacteria, is the leading cause of chronic gastritis and gastric cancer. Virulence and antibiotic resistance of H. pylori are of great concern to public health. However, the relationship between virulence and antibiotic resistance genes in H. pylori in relation to other campylobacteria remains unclear. Using the virulence and comprehensive antibiotic resistance databases, we explored all available 354 complete genomes of H. pylori and compared it with 90 species of campylobacteria for virulence and antibiotic resistance genes/proteins. On average, H. pylori had 129 virulence genes, highest among Helicobacter spp. and 71 antibiotic resistance genes, one of the lowest among campylobacteria. Just 2.6% of virulence genes were shared by all campylobacterial members, whereas 9.4% were unique to H. pylori. The cytotoxin-associated genes (cags) seemed to be exclusive to H. pylori. Majority of the isolates from Asia and South America were cag2-negative and many antibiotic resistance genes showed isolate-specific patterns of occurrence. Just 15 (8.8%) antibiotic resistance genes, but 103 (66%) virulence genes including 25 cags were proteomically identified in H. pylori. Arcobacterial members showed large variation in the number of antibiotic resistance genes and there was a positive relation with the genome size. Large repository of antibiotic resistance genes in campylobacteria and a unique set of virulence genes might have important implications in shaping the course of virulence and antibiotic resistance in H. pylori., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
48. Development and evaluation of a Lateral flow immunoassay (LFIA) prototype for the detection of IgG anti-SARS-CoV-2 antibodies.
- Author
-
Fogaça MBT, Saavedra DP, Lopes-Luz L, Ribeiro BM, da Silva Pinto L, Nagata T, Conceição FR, Stefani MMA, and Buhrer-Sékula S
- Abstract
Lateral flow immunoassays (LFIA) for antibody detection represent cost-effective and user-friendly tools for serology assessment. This study evaluated a new LFIA prototype developed with a recombinant chimeric antigen from the spike/S and nucleocapsid/N proteins to detect anti-SARS-CoV-2 IgG antibodies. The evaluation of LFIA sensitivity and specificity used 811 serum samples from 349 hospitalized, SARS-CoV-2 RT-qPCR positive COVID-19 patients, collected at different time points and 193 serum samples from healthy controls. The agreement between ELISA results with the S/N chimeric antigen and LFIA results was calculated. The LFIA prototype for SARS-CoV-2 using the chimeric S/N protein demonstrated 85 % sensitivity on the first week post symptoms onset, reaching 94 % in samples collected at the fourth week of disease. The agreement between LFIA and ELISA with the same antigen was 92.7 %, 0.827 kappa Cohen value (95 % CI [0.765-0.889]). Further improvements are needed to standardize the prototype for whole blood use. The inclusion of the novel chimeric S + N antigen in the COVID-19 IgG antibody LFIA demonstrated optimal agreement with results from a comparable ELISA, highlighting the prototype's potential for accurate large-scale serologic assessments in the field in a rapid and user-friendly format., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 Published by Elsevier Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
49. Antibacterial Activity of Oregano ( Origanum vulgare L.) Essential Oil Vapors against Microbial Contaminants of Food-Contact Surfaces.
- Author
-
Pinto L, Cervellieri S, Netti T, Lippolis V, and Baruzzi F
- Abstract
The antimicrobial effect of eight essential oils' vapors against pathogens and spoilage bacteria was assayed. Oreganum vulgare L. essential oil (OVO) showed a broad antibacterial effect, with Minimum Inhibitory Concentration (MIC) values ranging from 94 to 754 µg cm
-3 air, depending on the bacterial species. Then, gaseous OVO was used for the treatment of stainless steel, polypropylene, and glass surfaces contaminated with four bacterial pathogens at 6-7 log cfu coupon-1 . No viable cells were found after OVO treatment on all food-contact surfaces contaminated with all pathogens, with the exception of Sta. aureus DSM 799 on the glass surface. The antimicrobial activity of OVO after the addition of beef extract as a soiling agent reduced the Sta. aureus DSM 799 viable cell count by more than 5 log cfu coupon-1 on polypropylene and glass, while no viable cells were found in the case of stainless steel. HS-GC-MS analysis of the headspace of the boxes used for the antibacterial assay revealed 14 different volatile compounds with α-Pinene (62-63%), and p-Cymene (21%) as the main terpenes. In conclusion, gaseous OVO could be used for the microbial decontamination of food-contact surfaces, although its efficacy needs to be evaluated since it depends on several parameters such as target microorganisms, food-contact material, temperature, time of contact, and relative humidity.- Published
- 2024
- Full Text
- View/download PDF
50. Attenuation photochemical potential of Pontal of Paranapanema river waters (Brazil) from agrochemicals: geographical and temporal assessment.
- Author
-
de Souza Freitas G, Rodrigues NG, Lastre-Acosta AM, Feirreira-Pinto L, Teixeira ACSC, and Parizi MPS
- Abstract
Knowledge of the environmental photochemical fate of pesticides is essential to assess their potential impacts. However, there are few studies in the literature focused on the photochemical attenuation of micropollutants in Brazilian rivers. In this context, this study characterized the surface waters of the Pontal of Paranapanema region (region which concentrates more than 80% of Brazilian sugarcane cultivations), in order to determine its photochemical attenuation potential against micropollutants in different seasons. Thus, the steady-state concentrations of the photochemically produced reactive intermediates (PPRIs) (hydroxyl radical, HO
• ; singlet oxygen,1 O2 , and triplet-excited state chromophoric dissolved organic matter,3 CDOM* ), formed in the rivers, were simulated by using the APEX model (Aquatic Photochemistry of Environmentally-occurring Xenobiotics), considering the sunlight irradiance, water chemistry, and depth. Based on our simulations, these concentrations vary between 0.35 × 10-15 and 4.52 × 10-14 mol L-1 for HO• , 1.3 × 10-15 and 1.2 × 10--14 mol L-1 for3 CDOM* , and 2.5 × 10-15 and 2.5 × 10-14 mol L-1 for1 O2 . Finally, mathematical simulations were used for predicting persistence of pesticides atrazine (ATZ) and diuron (DIR) in Pontal of Paranapanema surface waters and the half-life times (t1/2 ) of the pollutants ranged from a few hours to one week., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.